|
Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas |
|
|
|
Titel: |
Phase I dose escalation and expansion study of golidocitinib, a highly selective JAK1 inhibitor, in relapsed or refractory peripheral T-cell lymphomas |
Auteur: |
Song, Y. Yoon, D.H. Yang, H. Cao, J. Ji, D. Koh, Y. Jing, H. Eom, H. Kwak, J. Lee, W. Lee, J. Shin, H. Jin, J. Wang, M. Yang, Z. Kim, W.S. Zhu, J. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 34 () nr. 11 pagina's 1055-1063 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|